Log in to save to my catalogue

Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic revie...

Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic revie...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e15faeb18fd048fe83f36c7b0f6564db

Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature

About this item

Full title

Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature

Publisher

England: BMJ Publishing Group Ltd

Journal title

Journal for immunotherapy of cancer, 2019-11, Vol.7 (1), p.319-11, Article 319

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

BackgroundMyasthenia gravis (MG) is a rare but life-threatening adverse event of immune checkpoint inhibitors (ICI). Given the limited evidence, data from a large cohort of patients is needed to aid in recognition and management of this fatal complication.MethodsWe reviewed our institutional databases to identify patients who had cancer and MG in t...

Alternative Titles

Full title

Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e15faeb18fd048fe83f36c7b0f6564db

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e15faeb18fd048fe83f36c7b0f6564db

Other Identifiers

ISSN

2051-1426

E-ISSN

2051-1426

DOI

10.1186/s40425-019-0774-y

How to access this item